Antiviral Therapy
Country
United Kingdom
Western Europe
Subject Area and Category
Medicine
└
Infectious Diseases
Q2
└
Pharmacology
Q2
└
Pharmacology (medical)
Q2
Publisher
SJR 2025
0.836
Q2
SJR Score
H-Index
96
Citations / Doc (2yr)
3.34
Total Docs. (latest)
18
Total Citations (3yr)
194
Publication type
Journals
ISSN
20402058, 13596535
Coverage
1996-2025
Journal Rank
#6,462
Subject Categories
Infectious Diseases
Q2
Pharmacology
Q2
Pharmacology (medical)
Q2
Subject Areas
Detailed Metrics
| Total Docs. (latest) | 18 |
| Total Docs. (3 years) | 74 |
| Total Refs. | 745 |
| Total Citations (3 years) | 194 |
| Citable Docs. (3 years) | 70 |
| Citations / Doc. (2 years) | 3.34 |
| Ref. / Doc. | 41.39 |
| % Female | 48.0% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Antiviral Therapy?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Antiviral Therapy has an SJR of 0.836 and is ranked Q2.
What is the SJR and quartile of Antiviral Therapy?
Antiviral Therapy has an SJR (SCImago Journal Rank) of 0.836 and its best quartile is Q2.
What is the H-index of Antiviral Therapy?
The H-index of Antiviral Therapy is 96, meaning 96 of its articles have each been cited at least 96 times.
Is Antiviral Therapy indexed in Scopus?
Yes. Antiviral Therapy is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.